Skip to main content
Log in

The impact of ammonia levels and dialysis on outcome in 202 patients with neonatal onset urea cycle disorders

  • Original Article
  • Published:
Journal of Inherited Metabolic Disease

Abstract

Neonatal onset hyperammonemia in patients with urea cycle disorders (UCDs) is still associated with high morbidity and mortality. Current protocols consistently recommend emergency medical and dietary management. In case of increasing or persistent hyperammonemia, with continuous or progressive neurological signs, dialysis is performed, mostly as ultima ratio. It is presently unknown whether the currently defined ammonia threshold (e.g., at 500 μmol/L) to start dialysis is useful to improve clinical outcome. A systematic review of clinical and biochemical data from published neonatal onset UCD patients was performed to identify factors determining clinical outcome and to investigate in which clinical and biochemical setting dialysis was most effective. A total of 202 patients (118 proximal and 84 distal UCDs) described in 90 case reports or case series were included according to predefined inclusion/exclusion criteria. Median age at onset was three days and mean ammonia that triggered start of dialysis was 1199 μmol/L. Seventy-one percent of all patients received any form of dialysis. Total mortality was 25% and only 20% of all patients had a “normal” outcome. In general, patients with higher ammonia levels were more likely to receive dialysis, but this had for most patients no influence on outcome. In conclusion, in severe neonatal onset hyperammonemia, the current practice of dialysis, which effectively clears ammonia, had no impact on outcome. It may be essential for improving outcome to initiate all available treatment options, including dialysis, as early as possible.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Ah Mew N, Krivitzky L, McCarter R, Batshaw M, Tuchman M, Urea Cycle Disorders Consortium of the Rare Diseases Clinical Research N (2013) Clinical outcomes of neonatal onset proximal versus distal urea cycle disorders do not differ. J Pediatr 162: 324–329.e1. https://doi.org/10.1016/j.jpeds.2012.06.065

  • Ah Mew N, Simpson KL, Gropman AL, Lanpher BC, Chapman KA, Summar ML (1993) Urea cycle disorders overview. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K (eds) (2017) GeneReviews(R), 2017/22/06. University of Washington, Seattle

  • Alfadhel M, Mutairi FA, Makhseed N, Jasmi FA, Al-Thihli K, Al-Jishi E, AlSayed M, Al-Hassnan ZN, Al-Murshedi F, Häberle J, Ben-Omran T (2016) Guidelines for acute management of hyperammonemia in the Middle East region. Ther Clin Risk Manag 12:479–487. https://doi.org/10.2147/TCRM.S93144

    Article  PubMed  PubMed Central  Google Scholar 

  • Bachmann C (2003) Outcome and survival of 88 patients with urea cycle disorders: a retrospective evaluation. Eur J Pediatr 162:410–416

    Article  PubMed  CAS  Google Scholar 

  • Batshaw ML (1983) Sodium benzoate and arginine: alternative pathway therapy in inborn errors of urea synthesis. Prog Clin Biol Res 127:69–83

    PubMed  CAS  Google Scholar 

  • Batshaw ML, MacArthur RB, Tuchman M (2001) Alternative pathway therapy for urea cycle disorders: twenty years later. J Pediatr 138:S46–S54 discussion S54-5

    Article  PubMed  CAS  Google Scholar 

  • Batshaw ML, Tuchman M, Summar M, Seminara J, Members of the Urea Cycle Disorders C (2014) A longitudinal study of urea cycle disorders. Mol Genet Metab 113:127–130. https://doi.org/10.1016/j.ymgme.2014.08.001

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Berry SA, Lichter-Konecki U, Diaz GA, McCandless SE, Rhead W, Smith W, Lemons C, Nagamani SC, Coakley DF, Mokhtarani M, Scharschmidt BF, Lee B (2014) Glycerol phenylbutyrate treatment in children with urea cycle disorders: pooled analysis of short and long-term ammonia control and outcomes. Mol Genet Metab 112:17–24. https://doi.org/10.1016/j.ymgme.2014.02.007

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Brassier A, Gobin S, Arnoux JB, Valayannopoulos V, Habarou F, Kossorotoff M, Servais A, Barbier V, Dubois S, Touati G, Barouki R, Lesage F, Dupic L, Bonnefont JP, Ottolenghi C, De Lonlay P (2015) Long-term outcomes in ornithine Transcarbamylase deficiency: a series of 90 patients. Orphanet J Rare Dis 10:58. https://doi.org/10.1186/s13023-015-0266-1

    Article  PubMed  PubMed Central  Google Scholar 

  • Brusilow S, Horwich A (2001) Urea cycle enzymes. In: Scriver C, Beaudet A, Sly W, Valle D (eds) The metabolic & molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 1909–1963

    Google Scholar 

  • Brusilow SW (1984) Arginine, an indispensable amino acid for patients with inborn errors of urea synthesis. J Clin Invest 74:2144–2148. https://doi.org/10.1172/JCI111640

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Brusilow SW, Valle DL, Batshaw M (1979) New pathways of nitrogen excretion in inborn errors of urea synthesis. Lancet 2:452–454

    Article  PubMed  CAS  Google Scholar 

  • Burgard P, Kölker S, Haege G, Lindner M, Hoffmann GF (2016) Neonatal mortality and outcome at the end of the first year of life in early onset urea cycle disorders-review and meta-analysis of observational studies published over more than 35 years. J Inherit Metab Dis 39:219–229. https://doi.org/10.1007/s10545-015-9901-1

    Article  PubMed  Google Scholar 

  • Choi JH, Lee BH, Kim JH, Kim GH, Kim YM, Cho J, Cheon CK, Ko JM, Lee JH, Yoo HW (2015) Clinical outcomes and the mutation spectrum of the OTC gene in patients with ornithine transcarbamylase deficiency. J Hum Genet 60:501–507. https://doi.org/10.1038/jhg.2015.54

    Article  PubMed  CAS  Google Scholar 

  • Diaz GA, Krivitzky LS, Mokhtarani M, Rhead W, Bartley J, Feigenbaum A, Longo N, Berquist W, Berry SA, Gallagher R, Lichter-Konecki U, Bartholomew D, Harding CO, Cederbaum S, SE MC, Smith W, Vockley G, Bart SA, Korson MS, Kronn D, Zori R, Merritt JL 2nd, CSN S, Mauney J, Lemons C, Dickinson K, Moors TL, Coakley DF, Scharschmidt BF, Lee B (2013) Ammonia control and neurocognitive outcome among urea cycle disorder patients treated with glycerol phenylbutyrate. Hepatology 57:2171–2179. https://doi.org/10.1002/hep.26058

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Enns GM, Berry SA, Berry GT, Rhead WJ, Brusilow SW, Hamosh A (2007) Survival after treatment with phenylacetate and benzoate for urea-cycle disorders. N Engl J Med 356:2282–2292

    Article  PubMed  CAS  Google Scholar 

  • Go H, Imamura T, Hashimoto K, Ogasawara K, Sakamoto O, Takubo N, Momoi N, Hosoya M (2012) Successful prospective management of neonatal citrullinemia. J Pediatr Endocrinol Metab 25:371–373

    Article  PubMed  Google Scholar 

  • Häberle J (2013) Clinical and biochemical aspects of primary and secondary hyperammonemic disorders. Arch Biochem Biophys 536:101–108. https://doi.org/10.1016/j.abb.2013.04.009

    Article  PubMed  CAS  Google Scholar 

  • Häberle J, Boddaert N, Burlina A, Chakrapani A, Dixon M, Huemer M, Karall D, Martinelli D, Sanjurjo Crespo P, Santer R, Servais A, Valayannopoulos V, Lindner M, Rubio V, Dionisi-Vici C (2012) Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet J Rare Dis 7:32

    Article  PubMed  PubMed Central  Google Scholar 

  • Häberle J, Rubio V (2016) Disorders of the urea cycle and related enzymes. In: Saudubray JM, Baumgartner M, Walter JH (eds) Inborn metabolic diseases, 6th edn. Springer, Heidelberg, pp 295–308

  • Hanudel M, Avasare S, Tsai E, Yadin O, Zaritsky J (2014) A biphasic dialytic strategy for the treatment of neonatal hyperammonemia. Pediatr Nephrol 29:315–320. https://doi.org/10.1007/s00467-013-2638-x

    Article  PubMed  PubMed Central  Google Scholar 

  • Häussinger D (1990) Nitrogen metabolism in liver: structural and functional organization and physiological relevance. Biochem J 267:281–290

    Article  PubMed  PubMed Central  Google Scholar 

  • Jalan A, Kudalkar K, Joshi M, Shirke S, Mahamunkar A, Jalan R, Shinde D, Borugale M, Tawde R, Häberle J (2016) Survival and outcome of patients with urea cycle disorders: a single-center experience. Perinatology 17:110–119

    Google Scholar 

  • Jorda A, Rubio V, Portoles M, Vilas J, Garcia-Pino J (1986) A new case of arginase deficiency in a Spanish male. J Inherit Metab Dis 9:393–397

    Article  PubMed  CAS  Google Scholar 

  • Keskinen P, Siitonen A, Salo M (2008) Hereditary urea cycle diseases in Finland. Acta Paediatr 97:1412–1419

    Article  PubMed  Google Scholar 

  • Kido J, Nakamura K, Mitsubuchi H, Ohura T, Takayanagi M, Matsuo M, Yoshino M, Shigematsu Y, Yorifuji T, Kasahara M, Horikawa R, Endo F (2012) Long-term outcome and intervention of urea cycle disorders in Japan. J Inherit Metab Dis 35:777–785. https://doi.org/10.1007/s10545-011-9427-0

    Article  PubMed  CAS  Google Scholar 

  • Kölker S, Cazorla AG, Valayannopoulos V, Lund AM, Burlina AB, Sykut-Cegielska J, Wijburg FA, Teles EL, Zeman J, Dionisi-Vici C, Baric I, Karall D, Augoustides-Savvopoulou P, Aksglaede L, Arnoux JB, Avram P, Baumgartner MR, Blasco-Alonso J, Chabrol B, Chakrapani A, Chapman K, EC IS, Couce ML, de Meirleir L, Dobbelaere D, Dvorakova V, Furlan F, Gleich F, Gradowska W, Grunewald S, Jalan A, Häberle J, Haege G, Lachmann R, Laemmle A, Langereis E, de Lonlay P, Martinelli D, Matsumoto S, Muhlhausen C, de Baulny HO, Ortez C, Pena-Quintana L, Ramadza DP, Rodrigues E, Scholl-Bürgi S, Sokal E, Staufner C, Summar ML, Thompson N, Vara R, Pinera IV, Walter JH, Williams M, Burgard P (2015) The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation. J Inherit Metab Dis 38:1041–1057. https://doi.org/10.1007/s10545-015-9839-3

    Article  PubMed  CAS  Google Scholar 

  • Leonard JV, Morris AA (2002) Urea cycle disorders. Semin Neonatol 7:27–35

    Article  PubMed  CAS  Google Scholar 

  • Martin-Hernandez E, Aldamiz-Echevarria L, Castejon-Ponce E, Pedron-Giner C, Couce ML, Serrano-Nieto J, Pintos-Morell G, Belanger-Quintana A, Martinez-Pardo M, Garcia-Silva MT, Quijada-Fraile P, Vitoria-Minana I, Dalmau J, Lama-More RA, Bueno-Delgado MA, Del Toro-Riera M, Garcia-Jimenez I, Sierra-Corcoles C, Ruiz-Pons M, Pena-Quintana LJ, Vives-Pinera I, Morais A, Balmaseda-Serrano E, Meavilla S, Sanjurjo-Crespo P, Perez-Cerda C (2014) Urea cycle disorders in Spain: an observational, cross-sectional and multicentric study of 104 cases. Orphanet J Rare Dis 9:187. https://doi.org/10.1186/s13023-014-0187-4

    Article  PubMed  PubMed Central  Google Scholar 

  • McBride KL, Miller G, Carter S, Karpen S, Goss J, Lee B (2004) Developmental outcomes with early orthotopic liver transplantation for infants with neonatal-onset urea cycle defects and a female patient with late-onset ornithine transcarbamylase deficiency. Pediatrics 114:e523–e526. https://doi.org/10.1542/peds.2004-0198

    Article  PubMed  Google Scholar 

  • Morioka D, Kasahara M, Takada Y, Shirouzu Y, Taira K, Sakamoto S, Uryuhara K, Egawa H, Shimada H, Tanaka K (2005) Current role of liver transplantation for the treatment of urea cycle disorders: a review of the worldwide English literature and 13 cases at Kyoto University. Liver Transpl 11:1332–1342

    Article  PubMed  Google Scholar 

  • Msall M, Batshaw ML, Suss R, Brusilow SW, Mellits ED (1984) Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies. N Engl J Med 310:1500–1505

    Article  PubMed  CAS  Google Scholar 

  • Nakamura K, Kido J, Mitsubuchi H, Endo F (2014) Diagnosis and treatment of urea cycle disorder in Japan. Pediatr Int 56:506–509. https://doi.org/10.1111/ped.12439

    Article  PubMed  CAS  Google Scholar 

  • Nassogne MC, Heron B, Touati G, Rabier D, Saudubray JM (2005) Urea cycle defects: management and outcome. J Inherit Metab Dis 28:407–414. https://doi.org/10.1007/s10545-005-0303-7

    Article  PubMed  CAS  Google Scholar 

  • Palmieri F (2008) Diseases caused by defects of mitochondrial carriers: a review. Biochim Biophys Acta 1777:564–578. https://doi.org/10.1016/j.bbabio.2008.03.008

    Article  PubMed  CAS  Google Scholar 

  • Picca S, Dionisi-Vici C, Abeni D, Pastore A, Rizzo C, Orzalesi M, Sabetta G, Rizzoni G, Bartuli A (2001) Extracorporeal dialysis in neonatal hyperammonemia: modalities and prognostic indicators. Pediatr Nephrol 16:862–867

    Article  PubMed  CAS  Google Scholar 

  • Picca S, Dionisi-Vici C, Bartuli A, De Palo T, Papadia F, Montini G, Materassi M, Donati MA, Verrina E, Schiaffino MC, Pecoraro C, Iaccarino E, Vidal E, Burlina A, Emma F (2015) Short-term survival of hyperammonemic neonates treated with dialysis. Pediatr Nephrol 30:839–847. https://doi.org/10.1007/s00467-014-2945-x

    Article  PubMed  Google Scholar 

  • Picker JD, Puga AC, Levy HL, Marsden D, Shih VE, Degirolami U, Ligon KL, Cederbaum SD, Kern RM, Cox GF (2003) Arginase deficiency with lethal neonatal expression: evidence for the glutamine hypothesis of cerebral edema. J Pediatr 142:349–352. https://doi.org/10.1067/mpd.2003.97

    Article  PubMed  Google Scholar 

  • Sancho-Vaello E, Marco-Marin C, Gougeard N, Fernandez-Murga L, Rüfenacht V, Mustedanagic M, Rubio V, Häberle J (2016) Understanding N-acetyl-L-glutamate synthase deficiency: mutational Spectrum, impact of clinical mutations on enzyme functionality, and structural considerations. Hum Mutat 37:679–694. https://doi.org/10.1002/humu.22995

    Article  PubMed  CAS  Google Scholar 

  • Schaefer F, Straube E, Oh J, Mehls O, Mayatepek E (1999) Dialysis in neonates with inborn errors of metabolism. Nephrol Dial Transplant 14:910–918

    Article  PubMed  CAS  Google Scholar 

  • Summar M, Pietsch J, Deshpande J, Schulman G (1996) Effective hemodialysis and hemofiltration driven by an extracorporeal membrane oxygenation pump in infants with hyperammonemia. J Pediatr 128:379–382

    Article  PubMed  CAS  Google Scholar 

  • Summar ML, Koelker S, Freedenberg D, Le Mons C, Häberle J, Lee HS, Kirmse B (2013) The incidence of urea cycle disorders. Mol Genet Metab 110:179–180. https://doi.org/10.1016/j.ymgme.2013.07.008

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Takahashi T, Yamada K, Kobayashi H, Hasegawa Y, Taketani T, Fukuda S, Yamaguchi S (2015) Metabolic disease in 10 patients with sudden unexpected death in infancy or acute life-threatening events. Pediatr Int 57:348–353. https://doi.org/10.1111/ped.12660

    Article  PubMed  Google Scholar 

  • Uchino T, Endo F, Matsuda I (1998) Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan. J Inherit Metab Dis 21(Suppl 1):151–159

    Article  PubMed  Google Scholar 

  • van Karnebeek C, Häberle J (2015) Carbonic anhydrase VA deficiency. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K (eds) GeneReviews, 2015/04/04 edn. University of Washington, Seattle

  • Vandenbroucke JP (2001) In defense of case reports and case series. Ann Intern Med 134:330–334

    Article  PubMed  CAS  Google Scholar 

  • Woo HI, Ki CS, Lee SY, Kim JW, Song J, Jin DK, Park WS, Lee DH, Lee YW, Park HD (2013) Mutation spectrum of the ASS1 gene in Korean patients with citrullinemia type I. Clin Biochem 46:209–213. https://doi.org/10.1016/j.clinbiochem.2012.10.008

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by the Swiss National Science Foundation (grant 310030_153196). The authors are grateful to Jin-Ho Choi & Han-Wook Yoo, MD, PhD, Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, who helped to complete missing data.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Johannes Häberle.

Ethics declarations

None.

Studies with human or animal

This article does not contain any studies with human or animal subjects performed by the authors.

Additional information

Responsible Editor: Carlo Dionisi-Vici

Electronic supplementary material

ESM 1

(DOCX 141 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hediger, N., Landolt, M.A., Diez-Fernandez, C. et al. The impact of ammonia levels and dialysis on outcome in 202 patients with neonatal onset urea cycle disorders. J Inherit Metab Dis 41, 689–698 (2018). https://doi.org/10.1007/s10545-018-0157-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10545-018-0157-4

Navigation